Trial Profile
A phase II trial of FGI 1011A6.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2011
Price :
$35
*
At a glance
- Drugs FGI 1011A6 (Primary)
- Indications Viral infections
- Focus Therapeutic Use
- 04 Nov 2011 New trial record